Agios Pharmaceuticals (8AP.F) Q2 2025 Earnings

May 1Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.62
3.89
9.4
14.9

Details

Expected EPS
-1.56761221514
Actual EPS
-1.372339
Surprise EPS
0.2
Surprise Percent
+12.46%

Description

⁨Agios Pharmaceuticals⁩ (⁦8AP.F⁩) has reported earnings of ⁦-1.372339⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts